HEALIOS K.K.

Research HEALIOS K.K. (6VX) on Bullrun: market cap EUR 164.70M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker6VX
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 164.70M
• Financial periodFY2025
• RevenueEUR 104.00M
• Revenue growth-81.4%
• Net income-EUR 2.22B
• Free cash flow-EUR 3.33B
• Gross margin-109.6%

Valuation Snapshot

latest market cap is EUR 164.70M.

About HEALIOS K.K.

Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ischemic stroke;

Frequently asked questions

What is HEALIOS K.K.'s market cap?

HEALIOS K.K.'s market capitalization is EUR 164.70M.

What does HEALIOS K.K. do?

Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.